- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04805359
Effect of Hypoxia Exercise on Erythrocyte Aggregability
March 16, 2021 updated by: Jong-Shyan Wang, Chang Gung Memorial Hospital
Pathological erythrocyte aggregation reduces capillary perfusion and oxygen transfer to tissue.
The aggregation is determined by opposing forces, the repulsive force between cells, cell-to-cell adhesion induced by plasma fibrinogen, and the disaggregating shear force generated by blood flow.
The investigators investigate how hypoxic exercise affects intrinsic/extrinsic factors of aggregation.
Sixty sedentary males were randomly assigned into either hypoxic (HE; FiO2=15%, n=20) or normoxic (NE; FiO2=21%, n=20) training groups for 30 min·d-1, 5 d·wk-1 for 6 weeks at 60% of maximum work rate or to a control group (CTL; n=20).
A hypoxia exercise test (HET, FiO2=12%) was performed before and after the intervention.
The erythrocyte aggregation, binding affinity of fibrinogen and membrane biomarkers were determined by an ektacytometry and flow cytometry, respectively.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The aim of this study is to clarify the effects of exercise training with and without hypoxia on the erythrocyte aggregation, further providing a feasible strategy for developing an appropriate exercise regimen that improves cardiopulmonary fitness and minimizes the risk of hemorheological disorders.
This study evaluated the distinct effects of hypoxic exercise training (HE) and normaxia exercise training (NE) for 6 weeks on the following issue: (1) intrinsic/extrinsic erythrocyte aggregation, (2) binding affinity of fibrinogen to erythrocyte, (3) erythrocyte turnover rate and (4) characteristic of mature erythrocytes in blood, under hypoxic exercise test (HET) (100W under air 12% O2 condition) in healthy sedentary men.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Having a sedentary lifestyle (without regular exercise, exercise frequency ≤ once weekly, duration < 20 min).
Exclusion Criteria:
- Exposed to high altitudes (> 3000 m) for at least 1 year.
- Smoker
- Taking medications or vitamins
- Having any cardiopulmonary/hematological risk.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Normoxic exercise (NE)
The subjects were trained on a bicycle ergometer at 60% of maximal work-rate (60%Wmax) under 21%O2 in air (NE) for 30 minutes per day, 5 days per week for 6 weeks
|
Trained on a bicycle ergometer at 60% of maximal work-rate (60%Wmax)for 30 minutes per day, 5 days per week for 6 weeks
|
|
Experimental: Hypoxic exercise (HE)
The subjects were trained on a bicycle ergometer at 60% of maximal work-rate (60%Wmax) under 15%O2 in air (HE) for 30 minutes per day, 5 days per week for 6 weeks
|
Trained on a bicycle ergometer at 60% of maximal work-rate (60%Wmax)for 30 minutes per day, 5 days per week for 6 weeks
|
|
No Intervention: Normoxic control
Without any exercise training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Erythrocyte Aggregation
Time Frame: 8 weeks
|
The total erythrocyte aggregation was determined by using Microfluidic Ektacytometer (Rheoscan-AnD 300, RheoMeditech, Seoul, Korea).
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiopulmonary capacity
Time Frame: 8 weeks
|
To assess cardiopulmonary capacity, the cardiopulmonary exercise test (CPET) on a cycle ergometer was performed 4 days before and after the intervention.
All subjects underwent exercise with a mask to measured oxygen consumption (VO2) breath by breath using a computer-based system (Master Screen CPX, Cardinal-health Germany).
After 5-min baseline resting period records, a 2-min warm-up period (60 rpm, unloaded pedaling) was started and followed by an incremental work (30 W elevation for each 3-minute) until exhaustion (i.e., progressive exercise to maximal O2 consumption, VO2max).
|
8 weeks
|
|
The affinity between erythrocyte and fibrinogen
Time Frame: 8 weeks
|
|
8 weeks
|
|
Senescence-Related Molecules on Erythrocyte
Time Frame: 8 weeks
|
Erythrocyte suspensions (1x10^6 cells /µl) were incubated with monoclonal anti- CD147(eBioscience) and anti-CD47(BioLegend) that were conjugated with FITC in the dark for 30 min at 37°C.
The MFI obtained from 50,000 erythrocytes was measured by using FACSCalibur.
|
8 weeks
|
|
Adhesion-Related Molecules on Erythrocyte
Time Frame: 8 weeks
|
Erythrocyte suspensions (1x10^6 cells /µl) were incubated with monoclonal anti-CD49d (eBioscience) and anti- CD36(BioLegend) that were conjugated with FITC in the dark for 30 min at 37°C.
The MFI obtained from 50,000 erythrocytes was measured by using FACSCalibur.
|
8 weeks
|
|
The influences of fibrinogen to erythrocytes
Time Frame: 8 weeks
|
|
8 weeks
|
|
The influences of the intrinsic factor to erythrocytes
Time Frame: 8 weeks
|
|
8 weeks
|
|
The influences of the extrinsic factor to erythrocytes
Time Frame: 8 weeks
|
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 5, 2010
Primary Completion (Actual)
June 30, 2011
Study Completion (Actual)
June 30, 2011
Study Registration Dates
First Submitted
February 25, 2021
First Submitted That Met QC Criteria
March 16, 2021
First Posted (Actual)
March 18, 2021
Study Record Updates
Last Update Posted (Actual)
March 18, 2021
Last Update Submitted That Met QC Criteria
March 16, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200903510B0
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoxia
-
Direction Centrale du Service de Santé des ArméesNot yet recruitingHypoxia | Hypoxia, Brain | Hypoxia in Healthy Individuals | Hypoxia, Altitude | Altitude Hypoxia | Altitude | Hypoxia Altitude Simulation Test | Hypoxia Brain | Normobaric HypoxiaFrance
-
Western University, CanadaCompletedBrain Hypoxia IschemiaCanada
-
Universite du Littoral Cote d'OpaleNot yet recruitingNormoxia | Intermittent Moderate Hypoxia | Continuous Moderate HypoxiaFrance
-
Jorge Torres MejíasEnrolling by invitationChanges in the Intestinal Microbiota Under Hypobaric Hypoxia Conditions | Changes in Blood Glucose Under Hypobaric Hypoxia Conditions | Changes in Body Composition Under Hypobaric Hypoxia Conditions | Determination of Physiological Stress in Hypobaric HypoxiaChile
-
Yale UniversityTianjin Chest HospitalCompletedBrain Ischemia Hypoxia | Muscle; Ischemic | Muscle HypoxiaChina
-
Fliegerärztliches InstitutCompleted
-
University of Texas at AustinCompletedIntermittent HypoxiaUnited States
-
Owlet Baby Care, Inc.Completed
-
Robert L. OwensCompletedIntermittent HypoxiaUnited States
-
Montreal Heart InstituteUniversité de MontréalCompleted
Clinical Trials on Normoxic exercise
-
Hannover Medical SchoolGerman Diabetes CenterCompleted
-
Centre Hospitalier Universitaire, AmiensNot yet recruitingSleep | Intermittent Hypoxia | Exercise Recovery | Intermittent Exercise | Rating Exertion PerceptionFrance
-
Charite University, Berlin, GermanyCompleted
-
University of NottinghamJozef Stefan Institute; European Commission; KTH Royal Institute of TechnologyCompleted
-
Norwegian University of Science and TechnologyAarhus University HospitalCompleted
-
University Hospital, GrenobleUnknown
-
Beth Israel Deaconess Medical CenterUnknownDelirium | Hyperoxia | NormoxicUnited States
-
Kementerian Riset dan Teknologi / Badan Riset dan...Dr. Moewardi General Hospital, Surakarta, Indonesia; Dr. Sardjito General Hospital... and other collaboratorsRecruiting
-
KU LeuvenCompletedHypoxia | Angiogenesis | KetosisBelgium